Clinartis is entirely focused on delivering projects through a collaborative and personalized approach. Our expertise in specific...READ MORE >>

WELCOME TO CLINARTIS

Clinartis is a dynamic contract research organization serving pharmaceutical, biotech and medical device companies to support Phase I - IV drug and device development in US and Eastern Europe, including Russia, Ukraine, Serbia, Baltic countries and others. We provide a broad range of services to meet specific requirements of clinical research development programs according to the standards of Good Clinical Practice (GCP) and International Conference on Harmonisation (ICH) guidelines.

Our broad therapeutic experience, strong project management capabilities, and core expertise in quality assurance and regulatory affairs enables us to address specific product development needs and mitigate obstacles often present in pharmaceutical and medical device development.  Clinartis is positioned to handle the most complex projects in variety of therapeutic areas covering the entire process of clinical development from study design through clinical study conduct and ultimately to regulatory submission. Organized by a group of clinical research, regulatory and quality professionals with diverse areas of expertise and experience, we offer a substantial global reach for clinical development programs, meeting the highest quality standards, and with utmost dedication to client satisfaction.

Clinartis is uniquely positioned to assist with your drug development programs. Our team of internal experts in collaboration with our network of physicians, regulatory professionals and scientists will help to move your novel scientific discoveries and innovative ideas to the market.

NEWS / UPDATES

April 18th, 2013
Carol Houts, the President of Clinartis, a global clinical research organization will be speaking at the upcoming ASQ Biomedical seminar, AUDIT AVALANCHE. More information available at our Blog .

February 15th, 2013
Clinartis Blog update: Reproductive Health Drugs Advisory Committee Meeting has been announce. More information available at our Blog .

January 18th, 2013
Clinartis attends the Orlando Dermatology Aesthetic & Clinical conference

October 10, 2012
Clinartis launches it's White Paper series with a paper on IND Enablement

October 3, 2012
Clinartis attends the 2012 North American Menopause Society Meeting in Orlando. For information regarding updates from the event see The Clinartis Blog

September 21, 2012
Clinartis attends the 2012 Reproductive Health Conference in New Orleans, LA

June 6, 2012
Clinartis has entered into a Letter of Intent with Regen BioPharma, a biotechnology company focused on the development translational medicine platforms for the rapid commercialisation of stem cell therapies. READ MORE>>

----------------------------------------------
CONTACT US
1909 Tyler Street, Suite 702
Hollywood, FL 33020
Phone: 954-404-8068
Fax: 954-589-0471
Email: info@clinartis.com

Follow our White Paper series here